logo

For the Inventor, By the Inventor

Hino, Japan

Yuri Sakai

This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Teijin Pharma Limited, Teijin Limited. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuri Sakai. Retrieved from https://idiyas.com/inventor/yuri-sakai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 75.0


Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Hino, JP (2009)
  • Tokyo, JP (2018 - 2021)

Company Filing History:

goldMedal3 out of 127 
 
Teijin Pharma Limited
 patents
silverMedal1 out of 1,605 
 
Teijin Limited
 patents

Years Active: 2009-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 11084814 - Pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof (2021-08-10),
2. 10124004 - Pyrido[3,4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof (2018-11-13),
3. 7557113 - Substituted pyrrolo[3,2-d]pyrimidine derivatives (2009-07-07),
4. 7528140 - Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors (2009-05-05),

Title: Innovations of Inventor Yuri Sakai

Introduction

Yuri Sakai is a notable inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic potential. With a total of 4 patents to his name, Sakai's work focuses on innovative solutions for medical challenges.

Latest Patents

Sakai's latest patents include a Pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof. The purpose of this invention is to provide a compound that exhibits excellent CDK4/6 inhibitory activity. This compound is represented by a specific formula, which highlights its potential in treating various diseases. Another patent also focuses on a Pyrido[3,4-d]pyrimidine derivative with similar objectives, emphasizing the importance of this class of compounds in pharmaceutical applications.

Career Highlights

Throughout his career, Yuri Sakai has worked with prominent companies such as Teijin Pharma Limited and Teijin Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Sakai has collaborated with talented individuals in his field, including Gen Unoki and Takaharu Tsutsumi. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Yuri Sakai's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…